2-(5-Piperidin-4-yl-1,2,4-oxadiazol-3-yl)pyrazine, 95.0%, 1g

1-(4-Chlorophenyl)-3-oxocyclobutane-1-carboxylic acid, 95%, 100mg

Methyl 5-fluoro-2-hydroxybenzoate, 95.0%, 5g

methyl 2-methyl-3-[(2-phenylethyl)amino]propanoate, 95.0%, 10g

(5-Chlorothiophen-2-yl)methanol, 95.0%, 10g

6-Chloro-3-(trifluoromethyl)pyridin-2-amine, 95.0%, 100mg

2-(Thiophen-2-yl)-1,3,2-dioxaborinane, 95.0%, 25g

2-Hydroxy-n-octanoic Acid, 95.0%, 5g

(4R,5S)-4-Methyl-5-phenyloxazolidin-2-one, 95.0%, 25g

2-Chloroquinazolin-4-amine, 95.0%, 10g

N-(4-Isopropoxybenzyl)cyclopropanamine hydrochloride, 5g

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-azaspiro[3.3]hept-5-ene-2-carboxylate, 98%, 250mg

Diacétylmonoxime, min 99%, pa, 25 g, emballage plastique.